Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Implantable Cardioverter Defibrillators (ICD) Pipeline Market Report Overview
An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. The ICD pipeline market research report provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
ICD Pipeline Market Segments
The key segments in the ICD pipeline market are Single Chamber Implantable Cardioverter Defibrillators (ICD) and Subcutaneous Implantable Cardioverter Defibrillators (ICD). In 2023, both the segments have equal number of pipeline products.
ICD Pipeline Market Segmentation by Territories
Some of the key territories in the ICD pipeline market are the US, Europe, China, Israel, Japan, South Korea, Taiwan, India, Mexico, and New Zealand. In 2023, the US has the highest number of pipeline products.
ICD Pipeline Market Analysis, by Territories, 2023 (%)
For more territory insights into the ICD pipeline market, download a free report sample
ICD Pipeline Market Segmentation by Regulatory Paths
The key regulatory paths in the ICD pipeline market are PMA, CE, NMPA, Shonin, BOPA, NIFDS, TGA, HAS, ICAC, and MDL. In 2023, PMA was the most followed regulatory path for pipeline products.
ICD Pipeline Market Analysis, by Regulatory Paths, 2023 (%)
For more regulatory paths into the ICD pipeline market, download a free report sample
ICD Pipeline Market- Competitive Landscape
Some of the key companies in the ICD pipeline market are Advanced BioInformatics GmbH, AIS Inc., Arrhythmia Dynamics LLC, AtaCor Medical Inc, Boston Scientific Corp, CardiaLen, Inc., Coridea, LLC, Impulse Dynamics Germany GmbH, InnerPulse Inc (Inactive), and Johns Hopkins University.
Arrhythmia Dynamics LLC: Arrhythmia Dynamics LLC (Arrhythmia Dynamics) focuses on smart defibrillator algorithm for treatment of cardiac arrhythmias. Arrhythmia Dynamics is headquartered in Madison, Connecticut, the US.
AtaCor Medical Inc: AtaCor Medical Inc, is a medical device company that designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing. The company is headquartered in United States.
Boston Scientific Corp: Headquartered in Marlborough, Massachusetts, the US, Boston Scientific Corp (Boston Scientific) is a medical technology company that is involved in the development, manufacturing and commercialization of devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery.
ICD Pipeline Market Report Overview
Key Territories | The US, Europe, China, Israel, Japan, South Korea, Taiwan, India, Mexico, New Zealand, Singapore, Costa Rica, El Salvador, Australia, and Canada |
Key Segments | Single Chamber Implantable Cardioverter Defibrillators (ICD) and Subcutaneous Implantable Cardioverter Defibrillators (ICD) |
Key Regulatory Paths | PMA, CE, NMPA, Shonin, BOPA, NIFDS, TGA, HAS, ICAC, and MDL |
Leading Companies | Advanced BioInformatics GmbH, AIS Inc., Arrhythmia Dynamics LLC, AtaCor Medical Inc, Boston Scientific Corp, CardiaLen, Inc., Coridea, LLC, Impulse Dynamics Germany GmbH, InnerPulse Inc (Inactive), and Johns Hopkins University |
Segments Covered in the Report
ICD Pipeline Market Segments Outlook
- Single Chamber Implantable Cardioverter Defibrillators (ICD)
- Subcutaneous Implantable Cardioverter Defibrillators (ICD)
ICD Pipeline Market Territories Outlook
- The US
- Europe
- China
- Israel
- Japan
- South Korea
- Taiwan
- India
- Mexico
- New Zealand
- Singapore
- Costa Rica
- El Salvador
- Australia
- Canada
ICD Pipeline Market Regulatory Paths Outlook
- PMA
- CE
- NMPA
- Shonin
- BOPA
- NIFDS
- TGA
- HAS
- ICAC
- MDL
Scope
- Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
- Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
- Reviews of major players involved in the pipeline product development.
- Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Implantable Cardioverter Defibrillators (ICD) pipeline products.
- Review of Recent Developments in the segment / industry
Reasons to Buy
The Implantable Cardioverter Defibrillators (ICD) report enables you to:
- Access significant competitor information, analysis, and insights to improve your R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
- Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development.
- Formulate market-entry and market expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
AIS Inc.
Arrhythmia Dynamics LLC
AtaCor Medical Inc
Boston Scientific Corp
CardiaLen, Inc.
Coridea, LLC
Impulse Dynamics Germany GmbH
InnerPulse Inc (Inactive)
Johns Hopkins University
Kenergy Inc.
Massachusetts General Hospital
Max Planck Institute for Dynamics and Self-Organization
Medicool Technologies Inc
Medtronic Inc
Medtronic Plc
MicroPort CRM SA
MicroPort Scientific Corp
Smartwave Medical Ltd (Inactive)
University of Chicago
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key territories in the ICD pipeline market?
Some of the key territories in the ICD pipeline market are the US, Europe, China, Israel, Japan, South Korea, Taiwan, India, Mexico, and New Zealand.
-
What are the key segments in the ICD pipeline market?
The key segments in the ICD pipeline market are Single Chamber Implantable Cardioverter Defibrillators (ICD) and Subcutaneous Implantable Cardioverter Defibrillators (ICD).
-
What are the key regulatory paths in the ICD pipeline market?
The key regulatory paths in the ICD pipeline market are PMA, CE, NMPA, Shonin, BOPA, NIFDS, TGA, HAS, ICAC, and MDL.
-
What is an Implantable Cardioverter Defibrillator (ICD)?
An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.